Onward Medical N.V. (EBR: ONWD)
4.760
-0.030 (-0.63%)
Sep 4, 2024, 3:35 PM CET
Onward Medical Company Description
Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord.
The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs.
Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.
Country | Netherlands |
Founded | 2014 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 99 |
CEO | David Marver |
Contact Details
Address: Schimmelt 2 Eindhoven, NL-5656 Netherlands | |
Website | onwd.com |
Stock Details
Ticker Symbol | ONWD |
Exchange | Euronext Brussels |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | NL0015000HT4 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
David L. Marver | Chief Executive Officer and Executive Director |
Dr. Gregoire Courtine Ph.D. | Chief Scientific Officer and Director |
Khaled Bahi | Interim Chief Financial Officer |
Robert W. Odell | Vice President of Operations |
Lorenzo Fanti | Vice President of Legal |
Sarah Moore | Vice President of Global Marketing |
Julie Crom | Director of People and Culture |